Related Experiment Videos
Combined versus sequential phacotrabeculectomy with intraoperative 5-fluorouracil
1University of Chile, Santiago, Chile.
Journal of Cataract and Refractive Surgery
|January 26, 2000
Summary
Combined cataract and glaucoma surgery offers similar intraocular pressure (IOP) lowering effects to repeat glaucoma surgery after phacoemulsification, both using 5-fluorouracil (5-FU). Both procedures provide effective IOP management for glaucoma patients.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Cataract Surgery
Background:
- Glaucoma and cataracts often coexist, requiring surgical intervention.
- Phacoemulsification is standard for cataract removal.
- Trabeculectomy is a common glaucoma surgery to lower intraocular pressure (IOP).
Purpose of the Study:
- To compare the IOP-lowering efficacy of single-incision combined phacoemulsification and trabeculectomy versus phacoemulsification after prior trabeculectomy.
- Both surgical approaches utilized an intraoperative dose of 5-fluorouracil (5-FU).
Main Methods:
- Retrospective analysis of 18 eyes (Group 1) undergoing phacoemulsification after previous trabeculectomy with intraoperative 5-FU.
- Comparison with 22 matched eyes (Group 2) undergoing combined phacoemulsification and trabeculectomy with intraoperative 5-FU.
- Postoperative IOP and survival curves (IOP < 20 mm Hg and IOP ≤ 15 mm Hg) were analyzed using paired Student t test and log-rank analysis.
Main Results:
- Mean postoperative IOP was similar between groups (12.6 mm Hg in Group 1 vs. 12.2 mm Hg in Group 2; P = .64).
- Group 2 showed a trend towards significant IOP decrease (P = .0575), while Group 1 did not.
- No significant difference in survival curves was observed between groups based on IOP criteria (P = .333 and P = 1.00).
Conclusions:
- Combined cataract and glaucoma surgery with intraoperative 5-FU demonstrates comparable long-term IOP control to repeat glaucoma surgery after phacoemulsification.
- Both surgical strategies effectively manage IOP in patients with coexisting cataracts and glaucoma.